跳至主要内容
临床试验/CTRI/2018/08/015338
CTRI/2018/08/015338已完成未知

A Non-interventional, multicentre study to assess prevalence of BRCA1 and BRCA2 mutation among ovarian, primary peritoneal and fallopian tube cancer patients in India ( BRCA Study) - BRCA Study

AstraZeneca Pharma India Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Patients who provide written informed consent
  • 2. Female ââ?°Â¥ 18 years of age
  • 3. Previously or newly diagnosed ovarian, primary peritoneal, or fallopian tube cancer patients.

排除标准

  • 1. Patient with any medical condition that, in the opinion of the investigator, would interfere with safe completion of the study
  • 2. Patient participating in any other clinical study/ trial.

研究者

相似试验